BCG – leverancesituation
BCG-medac er på nuværende tidspunkt ikke tilgængeligt. Vi forventer en leveance i uge 51. Vi opdaterer information om leverancesituationen kontinuerligt.
Inlägg av Admin medac
Press release – Trecondi® (treosulfan)
TRECONDI® (treosulfan) by medac received EU-wide approval for toxicity-reducing conditioning therapy prior to allogeneic haematopoietic stem cell transplantation. Click here to view full Press release
Press release – Medac at EULAR 2019
Get the most out of MTX therapy Medac EULAR Symposium in Madrid with new data on how to improve therapy with the gold standard methotrexate. Click here to view full Press release
Medac app NMIBC Toolbox
NMIBC Toolbox er en 2-trins interaktiv hjælp til brug af EAU’s guidelines for ikke-muskelinvasiv blærekræft. 1) Det giver brugeren mulighed for at identificere risikoklassen for overfladiske blære tumorer med 6 diagnostiske faktorer, defineret i EAU retningslinjerne. 2) Den forbinder og viser kirurgiske og konservative installations regimer, som er anbefalet til den tilsvarende tumor risikoklasse af […]
Ny informationsfilm fra Blærecancerforeningen om blærecancer (norsk)
Her finder du filmen
Lomustine forbedrer overlevelsen for glioblastompatienter med metyleret MGMT promotor
Et studie anført af Prof. Herrlingen i Bonn, som blev præsenteret på 2017-mødet for Society for NeuroOncology, er nu publiceret i ”The Lancet”. „Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3” (Lancet 2019;393:678-88) Dette studie kan anses som en milepæl, […]
Medac has received the Yellow Hand Award
Medac received the Yellow Hand Award for the second consecutive time during the European Conference Oncology Pharmacy. The Yellow Hand Award is given by ESOP, European Society of Oncology Pharmacy. The Yellow Hand Award is awarded to companies who ensure safe transportation and handling of cystostatics throughout the complete supply chain and was first given in […]
Press release – First marketing authorisation worldwide for methotrexate in moderate psoriasis
Medac’s marketing authorisation extension gives many patients with psoriasis access to guidelines-based MTX therapy for the first time. Click here to view full Press release
Press release – Alacare®
Innovative therapeutic for the treatment of mild actinic keratoses – first self-adhesive patch for PDT The skin lesion actinic keratosis is associated with an estimated prevalence of up to 60 % in certain populations and bears a high disease burden being considered as precancerous The treatment option with the ALA-PDT patch has not only been […]
Press release
medac passes eco-audit and receives award for environmental management medac Gesellschaft für klinische Spezialpräparate mbH is innovative, successful, sustainable and environment-friendly. The pharmaceutical company has proven that economic prosperity and environmental responsibility are not necessarily a contradiction. To achieve perfect conditions for this objective, medac subjected itself to an auditing procedure according to EMAS and […]
